![Thomas Hancock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Hancock
Direttore/Membro del Consiglio presso
A&G Pharmaceutical, Inc.
Profilo
Thomas Edwin Hancock is currently a Director at Spectra Analysis Instruments, Inc., A&G Pharmaceutical, Inc., Cequent Pharmaceuticals, Inc., Nexus Medical LLC, and Magellan Biosciences, Inc. He previously worked as a Managing Director at U.S.
Bancorp, Managing Director & Senior Equity Analyst at Piper Sandler & Co. (Broker), Director at Stheno Corp., Director at Pacira CryoTech, Inc., Independent Director at Kiora Pharmaceuticals, Inc., Director at PathoLase, Inc., Finance Director at New England Partners, Research Scientist at COR Therapeutics, Inc., Principal at Genentech, Inc., Analyst at Bank of America Corp., Senior Analyst at Piper Sandler & Co. (Broker), Secretary & Vice President-Business Development at Geneva Acquisition Corp., Senior Analyst at Leerink Partners LLC, and Senior Research Associate at NationsBanc Montgomery Securities LLC.
He received his undergraduate and MBA degrees from the University of California, Berkeley.
Posizioni attive di Thomas Hancock
| Società | Posizione | Inizio |
|---|---|---|
A&G Pharmaceutical, Inc.
 A&G Pharmaceutical, Inc. BiotechnologyHealth Technology Develops and creates monoclonal antibodies to cancer-specific targets | Direttore/Membro del Consiglio | - |
Nexus Medical LLC
 Nexus Medical LLC Investment ManagersFinance Nexus Medical seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of medical technology and life science companies in various stages of development, including medical devices, diagnostics, biotechnology, specialty pharmaceutical and drug discovery tools. They prefer to lead their investments and to work in a hands-on manner with the portfolio companies, committing multiple partners to each investment. It provides financing for seed and early stage capital requirements. | Investitore di Private Equity | 01/01/1996 |
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and pharmaceuticals | Direttore/Membro del Consiglio | - |
Spectra Analysis Instruments, Inc.
 Spectra Analysis Instruments, Inc. Miscellaneous Commercial ServicesCommercial Services Supplies molecular spectroscopy systems and applications for chromatography | Direttore/Membro del Consiglio | - |
Magellan Biosciences, Inc.
 Magellan Biosciences, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for point-of-care systems, clinical laboratory instruments and analytical laboratory | Corporate Officer/Principal | - |
Precedenti posizioni note di Thomas Hancock
| Società | Posizione | Fine |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/04/2021 |
Stheno Corp.
 Stheno Corp. Medical SpecialtiesHealth Technology Develops non contact chemical detectors and detection systems | Direttore/Membro del Consiglio | 25/02/2010 |
Geneva Acquisition Corp.
 Geneva Acquisition Corp. Financial ConglomeratesFinance Operates as a special purpose acquisition company | Segretario Aziendale | 10/03/2009 |
Piper Sandler & Co. (Broker)
 Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 03/09/2003 |
| ░░░░░ ░░░░░░░ ░░░░░ ░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Thomas Hancock
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
19
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 19 |
|---|---|
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Bank of America Corp.
 Bank of America Corp. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer and global banking, markets brokerage & wealth and investment management services | Finance |
U.S. Bancorp
 U.S. Bancorp Major BanksFinance Operates as a bank holding company whose subsidiary provides national banking services | Finance |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Stheno Corp.
Stheno Corp. Medical SpecialtiesHealth Technology Develops non contact chemical detectors and detection systems | Health Technology |
Spectra Analysis Instruments, Inc.
Spectra Analysis Instruments, Inc. Miscellaneous Commercial ServicesCommercial Services Supplies molecular spectroscopy systems and applications for chromatography | Commercial Services |
A&G Pharmaceutical, Inc.
A&G Pharmaceutical, Inc. BiotechnologyHealth Technology Develops and creates monoclonal antibodies to cancer-specific targets | Health Technology |
Pacira CryoTech, Inc.
 Pacira CryoTech, Inc. Medical SpecialtiesHealth Technology Develops novel technologies for treatment of peripheral nerves | Health Technology |
Geneva Acquisition Corp.
Geneva Acquisition Corp. Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
PathoLase, Inc.
 PathoLase, Inc. Medical SpecialtiesHealth Technology Develops light-based disinfectant devices and procedures | Health Technology |
Cequent Pharmaceuticals, Inc.
Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and pharmaceuticals | Health Technology |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
NationsBanc Montgomery Securities LLC
 NationsBanc Montgomery Securities LLC Investment Banks/BrokersFinance Provides banking services | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New England Partners
 New England Partners Investment ManagersFinance NEP focuses on investing in companies in the technology, healthcare, and consumer product industries. Within the technology sector, they concentrate on investing in companies in the Internet, software, hardware and communications industries. In healthcare, they target biopharmaceutical, biotechnology, medical device and e-health companies. In consumer products, they seek companies that can offer distinctive products in a mass-market retail channel setting. The firm seeks early and later stage companies that are beyond the concept stage, have demonstrable technology and evidence of product or service acceptance. For companies with greater financial needs, NEP has a history of syndicating with other reputable venture capital or strategic investors. They participate in all stages of a company's equity financing needs, from a first institutional round of equity to a mezzanine round before an IPO. NEP concentrates on investing in companies that target potentially large markets. In addition, they work closely with portfolio companies in setting goals and financial objectives to maximize the overall financial return of the company and its investors. They seek to invest in companies that offer the potential for a relatively early initial public offering or sale to a strategic buyer. They also assist their portfolio companies in achieving liquidity by way of a sale to a financial investor or through a recapitalization. | Finance |
Nexus Medical LLC
Nexus Medical LLC Investment ManagersFinance Nexus Medical seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of medical technology and life science companies in various stages of development, including medical devices, diagnostics, biotechnology, specialty pharmaceutical and drug discovery tools. They prefer to lead their investments and to work in a hands-on manner with the portfolio companies, committing multiple partners to each investment. It provides financing for seed and early stage capital requirements. | Finance |
Magellan Biosciences, Inc.
Magellan Biosciences, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for point-of-care systems, clinical laboratory instruments and analytical laboratory | Health Technology |
